Hologic Inc (HOLX)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

$74.79

Buy

$75.25

arrow-up$0.01 (+0.01%)

Prices updated at 19 Dec 2025, 23:07 EST
| Prices minimum 15 mins delay
|
Prices in USD

Hologic Inc develops, manufactures and supplies diagnostics products, medical imaging systems and surgical products for women's health. Its products are used in diagnosis of human diseases and screen donated human blood and plasma.

Income statement

20242025
4,030m4,101m
2,228m2,118m
931m785m
23.1019.15
790m566m
1,296m1,098m
Sales, General and administrative995m1,070m
Interest expenses122m117m
Provision for income taxes76m116m
Operating expenses1,297m1,333m
Income before taxes865m681m
Net income available to common shareholders790m566m
3.192.5
Net interest income-13m-43m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)3.162.49
Free cash flow per share4.823.9754
Book value/share22.743422.6459
Debt equity ratio0.5054970.513758

Balance sheet

20242025
Current assets3,823m3,668m
Current liabilities1,037m977m
Total capital7,627m7,553m
Total debt2,658m2,627m
Total equity5,130m5,048m
Total non current liabilities--
Loans2,497m2,505m
Total assets9,156m9,015m
Total liabilities--
Cash and cash equivalents2,160m1,960m
Common stock232m223m

Cash flow

20242025
Cash at beginning of period2,756m2,160m
Cash dividends paid--
1,145m905m
Investments (gains) losses-781m-483m
2,160m1,960m
Net income--
1,285m1,057m
-140m-152m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.